A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2023-02-01
|
| Серія: | Journal of Microbiology, Immunology and Infection |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1684118222002869 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|